As a medical, marketing or market access manager in today’s complex pharmaceutical environment, it has become increasingly difficult to bring innovation and value “beyond the pill” in conversations with key stakeholders. Discussions, controversies and healthcare needs have far exceeded the simple task of providing a medication with a slightly better efficacy and safety profile to other options…
Several key abstracts were presented at #ASCO17 covering data in lymphoma and chronic lymphocytic leukemia (see bottom of this post for the abstract details): Abstract 7500: First-line treatment of iNHL or MCL patients with BR or R-CHOP/R-CVP: Results of the BRIGHT 5-year follow-up study. Abstract 7503: A genetic risk-stratified, randomized phase 2 intergroup study of fludarabine/antibody combinations…
The Canadian pharmaceutical market access environment can be quite complex at first blush. There are many agencies, organizations, and bodies to conform with along with a myriad of legislative bills and protocols to understand. This will be the first of many blogs that Impetus will create to help demystify this complex ecosystem in Canada. Our…
With the commencement of the American Society of Clinical Oncology (ASCO) Conference, the largest cancer focused conference in the world, we are reminded of the extraordinary number of innovations and achievements in research, in areas such as precision medicine and immunotherapy, that are helping to reshape the practice of cancer care today. Need for cancer clinical…
With over 38,000 attendees attending from all over the world, the American Society of Clinical Oncology (ASCO) Conference is the largest cancer focused conference in the world. For five consecutive days, stakeholders concerned about expanding cancer knowledge and improving cancer care for patients gather in Chicago to listen, speak, ask questions, interact at booths, read posters,…
In my recent post entitled “Step 3: How to select your best customers and resources” published on May 16, 2017, I discussed the third step in our Value Creator Process when developing a Campaign of Interactions with your advisors. It is comprised of deciding which of your customers in your stakeholder universe will be key in helping…
Impetus Digital’s market access virtual advisory board consists of 7 of the top ex-payers in Canada who are subject matter experts in pricing and market access submission processes. Our goal is to provide market access, reimbursement, pricing and health economics managers within Canadian pharma companies quick and economical access to key insights that will help…
Impetus Digital provides strategic planning, medical writing, project management and reporting for online asynchronous online assignments and web meetings so you can accomplish the following with your advisory boards and working groups: Gather timely clinical data insights Update and optimize investigator protocols and discuss trial developments Write peer reviewed journal articles, whitepapers, medical educational materials…
In my recent post entitled “Step 1: Isolating your brand’s key issues” published on May 4, 2017, I discussed the first step in our Value Creator Process when developing a Campaign of Interactions for your advisors. It is comprised of considering all the possible product and market factors impacting your brand and isolating the top 3-5 issues that are…
In my recent post entitled “Step 1: Isolating your brand’s key issues” published on May 4, 2017, I discussed the first step in our Value Creator Process when developing a Campaign of Interactions for your advisors. It is comprised of considering all the possible product and market factors impacting your brand and isolating the top…
